UPDATE: Goldman Sachs Upgrades Acadia Pharmaceuticals (ACAD) to Buy
Tweet Send to a Friend
(Updated - March 31, 2020 5:03 AM EDT)
(updating comment)Goldman Sachs analyst Salveen Richter upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Goldman Sachs analyst Salveen Richter upgraded Acadia Pharmaceuticals (NASDAQ: ACAD) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
